Search

everythinglearnresearchcommunity

for

Search:↓

Reducing the dose of Baricitinib to 2mg led to a loss of hair regrowth benefits in nearly half of the patients by Week-104.

LiPADI is a useful tool for monitoring the severity and treatment of lichen planus.

The CLASI is a reliable tool for measuring the severity of cutaneous lupus erythematosus.

The new tool helps measure the impact of alopecia areata on children's quality of life.

Organ transplant recipients have a higher risk of skin cancer over time, atopic dermatitis skin shows unusual bacterial and fungal patterns, a new tool for measuring hidradenitis suppurativa severity was created, and gene expression changes in male baldness suggest new treatments.

ALUDWIG can help standardize female hair loss assessment from a single image.

Experts recommend starting systemic treatment for alopecia areata when the condition is severe or causes significant distress.

Azelaic acid 20% cream works well for treating scalp alopecia areata and can be an alternative to clobetasol ointment.

Phototherapy effectively treats certain alopecia areata types, especially if started early.

Botulinum toxin type A did not help regrow hair in severe alopecia cases.

Janus kinase inhibitors are effective and safe for treating Alopecia Areata.

Ritlecitinib is safe and may effectively treat alopecia areata.

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

Tofacitinib and methotrexate successfully treated a woman's severe skin, joint, and hair loss issues.

Alopecia areata may be linked to higher heart disease risk.

Disease-specific tools better assess quality of life in alopecia areata patients.

Mesenchymal Stem Cell Conditioned Media can significantly regrow hair in alopecia areata patients.

Baricitinib helps long-term hair regrowth in severe alopecia areata patients.

Higher IL-19 levels are linked to more severe Alopecia Areata.

Alopecia areata significantly worsens quality of life, suggesting a need for mental health support.

The updated SALT II tool offers a more precise way to measure scalp hair loss.

Severe hair loss (androgenetic alopecia) is linked to higher risk of heart disease (cardiovascular atherosclerosis).

Clinicians should use evidence-based tools and consider mental health when assessing alopecia areata to guide treatment.

CP-690,550 significantly reduced itching in patients with moderate-to-severe plaque psoriasis.

Lower vitamin D levels are linked to more severe alopecia areata.

Higher MPV and CRP levels may indicate more severe alopecia areata.

New tools help doctors better assess and treat alopecia areata in kids by considering more than just hair loss.

Tofacitinib effectively promotes hair regrowth in alopecia areata with minimal side effects.

Alopecia areata significantly lowers quality of life, especially in personal and social areas, and more so if the patient is also depressed.

Experts agreed on guidelines to improve research on Frontal Fibrosing Alopecia.